Actinium Pharmaceuticals, Inc. (ATNM)
1.425
0.00 (0.00%)
USD |
NYAM |
Dec 10, 09:37
Actinium Pharmaceuticals Market Cap: 44.45M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcus Biosciences, Inc. | 3.109B |
| Apyx Medical Corp. | 156.79M |
| AbbVie, Inc. | 397.75B |
| Karyopharm Therapeutics, Inc. | 108.61M |
| NovaBay Pharmaceuticals, Inc. | 206.66M |
Market Cap Related Metrics
| PS Ratio | 493.94 |
| Price to Book Value | 3.225 |
| Price | 1.425 |
| Earnings Yield | -77.83% |